← All stocks

PRECISION BIOSCIENCES INC

DTIL Net buying
CIK 0001357874 #3786 in the set updated 18 Sep 2026
Bought (120 mo)
$2.12M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$5.59M
$922.34K on a plan · $4.14M straight out of an exercise
Sold at will
$523.94K
15 of 80 sales
Net
−$3.47M
+$1.60M against sales at will

By person

21 insiders · 119 transactions
1.4×

Michael Amoroso holds only 1.4 times base salary in stock. $934.63K of shares against $650.88K in salary for 2025.

Salary from the company's own proxy. The shares are what Michael Amoroso last reported holding, valued at $3.84, the price Common Stock was last bought or sold at on the open market here, on 18 Feb 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
JANTZ DEREK
Chief Scientific Officer
$1.62M (17) scheduled
−$1.62M
4,055,174
$15.57M
+5.5%
KANE MATTHEW R.
President and CEO
$1.61M (15) scheduled
−$1.61M
2,024,438
$7.77M
+11.0%
THOMSON DAVID S.
Chief Operating Officer
$1.24M (7) scheduled
−$1.24M
111,513
$428.21K
+2,434%
FMR LLC entity
See Remark 1
$800.00K (1)
+$800.00K
3,738,248
$14.35M
venBio Global Strategic Fund, L.P. entity
Director
$800.00K (1)
+$800.00K
4,265,141
$16.38M
Amoroso Michael
President and CEO
$616.53K (11) scheduled
−$616.53K
243,392
$934.63K
Scimeca Dario
General Counsel and Secretary
$169.10K (13) scheduled
−$169.10K
56,457
$216.79K
SMITH J. JEFFERSON
Chief Research Officer
$122.59K (7) scheduled
−$122.59K
121,926
$468.20K
YAO TONY DUNG LING
Director
$100.03K (1)
+$100.03K
166,903
$640.91K
Buehler Kevin
Director
$63.32K (3)
+$63.32K
49,137
$188.69K
Germano Geno J
Director
$47.57K (3)
+$47.57K
44,883
$172.35K
List Alan
Chief Medical Officer
$45.73K (6)
−$45.73K
4,488
$17.23K
Kelly John Alexander
Chief Financial Officer
$209.27K (7)
$164.22K (4) scheduled
+$45.05K
125,883
$483.39K
Brown Melinda
Director
$43.13K (5)
+$43.13K
44,346
$170.29K
Heery Christopher
Chief Medical Officer
$30.02K (2)
+$30.02K
2,485
$9.54K
Frankel Stanley
Director
$26.11K (2)
+$26.11K
40,478
$155.44K
+80,856%
ANSARI ABID
Chief Financial Officer
144,401
$554.50K
+6,737%
Schinazi Raymond F
Director
93,048
$357.30K
Pire Shari Lisa
Director
35,028
$134.51K
Barton Shane
VP & Corporate Controller
27,502
$105.61K
Wadsworth Samuel C.
Director
4,202
$16.14K

No percentages here. This company's share count has moved by a factor of 3.6 over the window, from 7,671,059 to 27,601,554 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
SMITH J. JEFFERSON
18 Feb 2026
Chief Research Officer
Sold on a plan
4,925
$3.84
$18.91K
Scimeca Dario
18 Feb 2026
General Counsel and Secretary
Sold on a plan
4,925
$3.84
$18.91K
Kelly John Alexander
18 Feb 2026
Chief Financial Officer
Sold on a plan
8,149
$3.84
$31.29K
Amoroso Michael
18 Feb 2026
President and CEO
Sold on a plan
20,559
$3.84
$78.95K
Amoroso Michael
22 Jan 2026
President and CEO
Sold on a plan
34,799
$4.17
$145.11K
Kelly John Alexander
21 Jan 2026
Chief Financial Officer
Sold on a plan
15,213
$4.03
$61.31K
Scimeca Dario
21 Jan 2026
General Counsel and Secretary
Sold on a plan
8,854
$4.03
$35.68K
Scimeca Dario
3 Nov 2025
General Counsel and Secretary
Sold on a plan
665
$6.49
$4.32K
Kelly John Alexander
3 Nov 2025
Chief Financial Officer
Sold on a plan
1,303
$6.49
$8.46K
Kelly John Alexander
3 Jul 2025
Chief Financial Officer
Sold on a plan
14,827
$4.26
$63.16K
Amoroso Michael
24 Mar 2025
President and CEO
Sold on a plan
964
$5.56
$5.36K
Scimeca Dario
4 Mar 2025
General Counsel and Secretary
Sold on a plan
272
$4.91
$1.34K
SMITH J. JEFFERSON
4 Mar 2025
Chief Research Officer
Sold on a plan
154
$4.91
$756.14
SMITH J. JEFFERSON
22 Jan 2025
Chief Research Officer
Sold on a plan
10,287
$4.79
$49.27K
Scimeca Dario
22 Jan 2025
General Counsel and Secretary
Sold on a plan
8,928
$4.79
$42.77K
Amoroso Michael
21 Jan 2025
President and CEO
Sold on a plan
36,838
$4.67
$172.03K
Scimeca Dario
4 Nov 2024
General Counsel and Secretary
Sold on a plan
588
$8.19
$4.82K
Scimeca Dario
10 Jun 2024
General Counsel and Secretary
Sold on a plan
93
$11.79
$1.10K
Scimeca Dario
2 May 2024
General Counsel and Secretary
Sold on a plan
272
$10.32
$2.81K
List Alan
22 Jan 2024
Chief Medical Officer
Sold on a plan
21,526
$0.36
$7.75K
Scimeca Dario
22 Jan 2024
General Counsel and Secretary
Sold on a plan
21,287
$0.36
$7.66K
Amoroso Michael
22 Jan 2024
President and CEO
Sold on a plan
137,390
$0.36
$49.46K
Amoroso Michael
3 Nov 2023
President and CEO
Sold on a plan
125,025
$0.40
$50.01K
Scimeca Dario
3 Nov 2023
General Counsel and Secretary
Sold on a plan
16,023
$0.40
$6.41K
Scimeca Dario
8 Jun 2023
General Counsel and Secretary
Sold on a plan
13,361
$0.75
$10.02K
List Alan
27 Apr 2023
Chief Medical Officer
Sold on a plan
7,771
$0.79
$6.14K
Amoroso Michael
22 Mar 2023
President and CEO
Sold on a plan
46,999
$0.82
$38.54K

What was left out

Form 4 filings counted 235
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 27
Sales straight out of an exercise 38
Sales at will 15
Transactions with no price 0
Shares from compensation/vesting 11,715,028
Sales filed before the plan box existed 8
History held since 29 Mar 2019